Rapid increase in occurrence of carbapenem-resistant Enterobacteriaceae in healthy rural residents in Shandong Province, China, from 2015 to 2017Show others and affiliations
2022 (English)In: Journal of Global Antimicrobial Resistance, ISSN 2213-7165, E-ISSN 2213-7173, Vol. 28, p. 38-42Article in journal (Refereed) Published
Abstract [en]
OBJECTIVES: The global increase in carbapenem-resistant Enterobacteriaceae (CRE) is a growing health concern. Infections caused by CRE are associated with increased mortality and length of hospital stay, emphasising the health and economic burden posed by these pathogens. Although CRE can inhabit the human gut asymptomatically, colonisation with CRE is associated with an increased risk of CRE infection and mortality. In this study, we investigated the occurrence and characteristics of CRE in faecal samples from healthy persons in 12 villages in Shandong Province, China.
METHODS: Screening for CRE in faecal samples was performed by selective cultivation. Minimum inhibitory concentrations (MICs) of meropenem were determined by the agar dilution method. Multilocus sequence typing (MLST) and carbapenemase gene carriage of the isolates were determined by whole-genome sequencing. Genetic relatedness of Escherichia coli isolates was determined by core genome MLST.
RESULTS: CRE carriage increased from 2.4% in 2015 to 13.4% in 2017. Most CRE isolates (93.0%) were E. coli and all carried NDM-type carbapenemases. Sequence types (STs) among the E. coli isolates were diverse. The single most common ST was the highly epidemic strain ST167, which was only observed in 2017.
CONCLUSION: We report a rapid increase in occurrence of CRE (from 2.4% to 13.4%) among faecal samples collected from healthy rural residents of Shandong Province from 2015 to 2017. Colonisation with CRE is known to increase the risk of CRE infection, and the worrying deterioration of the epidemiological situation in the region reported here indicates a need for further monitoring and possible interventions.
Place, publisher, year, edition, pages
Elsevier, 2022. Vol. 28, p. 38-42
Keywords [en]
Carbapenems, China, Drug resistance, Enterobacteriaceae, Epidemiology, Escherichia coli
National Category
Microbiology in the medical area Microbiology
Identifiers
URN: urn:nbn:se:oru:diva-107636DOI: 10.1016/j.jgar.2021.11.007ISI: 000816445500006PubMedID: 34896338Scopus ID: 2-s2.0-85122758327OAI: oai:DiVA.org:oru-107636DiVA, id: diva2:1788377
Funder
Swedish Research Council Formas, 2016-00640Swedish Research Council, D087980Region Östergötland, LIO-793191Region Östergötland, LIO-899871
Note
This study was funded by the National Natural Science Foundation of China [41771499, 81361138021], the Swedish Research Council [D0879801], the Swedish Research Council Formas [2016-00640], ALF Grants, Region Östergötland [LIO-793191 and LIO-899871], Shandong Key Research and Development Plan Project [2017GSF218062] and the Medical and Health Technology Development Program of Shandong Province [2017WS447].
2023-08-162023-08-162023-12-29Bibliographically approved